pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-23a |
Genomic Coordinates | chr19: 13836587 - 13836659 |
Synonyms | MIRN23A, hsa-mir-23a, miRNA23A, MIR23A |
Description | Homo sapiens miR-23a stem-loop |
Comment | This miRNA was previously named miR-23 . This finding was later retracted after the discovery that the regulated gene was human homolog of ES1 (HES1), whose function is unknown. |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-23a-5p | |||||||||
Sequence | 9| GGGGUUCCUGGGGAUGGGAUUU |30 | |||||||||
Evidence | Experimental | |||||||||
Experiments | Cloned | |||||||||
SNPs in miRNA |
|
|||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SAMD5 | ||||||||||||||||||||
Synonyms | dJ875H10.1 | ||||||||||||||||||||
Description | sterile alpha motif domain containing 5 | ||||||||||||||||||||
Transcript | NM_001030060 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SAMD5 | |||||||||||||||||||||
3'UTR of SAMD5 (miRNA target sites are highlighted) |
>SAMD5|NM_001030060|3'UTR 1 ATATCATTTTTGAGACCTCGTGGAGGACTGATGAGGTGCCTGAAGACTGGAAAAGGGCATATTTAGAACCTTCTTTCAAA 81 AAGGGAAATGGATGATGACCCTGGAAATACTCATCAGCTTAACTTTTTGCTTGGACAAATTCTGGAATAATCAACTTAGT 161 AAACTGGGTAACTGGCTTATAACAGCTAGAAATAAGGCAGTGAACTATCACGCATAAAGAAGTATTGAGTTCATTTTTTT 241 AAGAAGATATCATGATGAGATACAGTCTTATGCATTTCTTGGCATTCTCCCTTCCATTCTTAATGAAAACAGATGAGGTT 321 GGCTAAGGCATTTGAGTCATAACTTAGTTTAAGTACAATATAACAAAAAGGTAGATTTCTGACAGTAAGTAGTAATTATA 401 TTATTTCCAAATTTGCTTTTAACTTGAGAACAGTAGCTTTAATTTTTATATTCAAGCATACATTCTACTTCATTTCATAT 481 AGGACCATGTTTTTATAAGATAAGATACATAATTCTATGTAGAATAGTTTGGTGAAGGAATTCTTATTTTAAGGTGCTTT 561 TATATAGTTATTTTGTATATTGGTACAATGTTAAAGGTGATGAATTAAGGAACATCACCAAGAGAGGACAATTTCTTCTA 641 ACTTCTCTTTTTAAATTTAATCTGGCTGAGGTTTAGTATTAGGACTAATACAAGTGTCTTGCTCTGACATGCATCAAGCA 721 AGAGCTAGCTATTTTACTTCATAGCTAGTTTCTTGCACTCTGTGGAGACTGCCAGGGCCGCAGCTCACAGCCTGTTCTGA 801 GCTGCAGTGCTTTATCCCACCTTGCTCTCCAGGCTTCTGACTTCAGGCCTGTGGGGGCCGGGAGGTGGGCAGCGGCAGTG 881 GCCTGAGGAGCCCTGTAGAACTACGGCTGAAAAAGAAAGTAGATTGAGGTGGGGGGAGGAAATTAACAGGAATCTAGAGT 961 TTTTCTAATTCTTATCGTCTTATCGTTCTTGTGTTTGGATGCTGGTAGTTTTTTTTTTTTTAGACAGAGTCTCGCTCTGT 1041 CACCCAGGCTGGAGTGTAGTGGCACAATCTTGGCTCACAGTGACTTTCGCCTCCCAGGTTCAAGGAATTCTCCTGCCTCG 1121 GCCTCTTGGTAGCTGGGATTACAGGCACGCATCACCACACCCAGCTAATTTTTTTGTATTTTTAGTAGAGATGGGGTTTT 1201 ACCATGTTGGCCAGGCTGTTCTTGAACTCCTGGCCTCAAATGATCCACTCGCCGTGGCCTCCAGTAGCGCTGGGATTACA 1281 GGCGTGAGCCATCACACCCGGCCTGGATGCTGGTAGTTTTATTTTCTGCTTAGAAAACGCAACCATGTTGATGGGACCAA 1361 AAACTTAGTTGAAAGAAGCCATGGCAAAAGATGTTGACGTACAACTGGCTCCTGAGGCTGTCAATTGTTTAGAGCTCCCA 1441 AGTAGTACTGCATTACGGAATCTACTACTTAGAAGAATGTACAAGATGTAAGTTCCCATCGGCACCGTCATGGTAAGAAG 1521 AATAAGAAACTCTCAAAGGAAAAGAAACTTACATTCACTTTTTCCTGGTCCATTTTGGTTCCTAAGAATAGATAGGCCAT 1601 TAAGAAGGATATTAGGTTTCTAAGGACAATTTTAACACAATACTGCTTTAAAAATCTGAAGTTTAAATAGTTTAGCTATT 1681 TCTGTAGGTTAATTCAGGCACTGACTAAAATCAGTCTCATTATCATATACAAATGTAAGGAAGTTAAATTTTAAAAGCAT 1761 GTATAGGTTGTCCTTAAATTATACAAAAGCTTTTAGTTTCATCAGGATTATATTCCAGTTAACCTTTCATCTTTTTTTTT 1841 TTTCCAAATGAACTAGGGTCTTTAAAATTCCTAAGTAGATTCTTTTGAGTGGTAGGGGAGTCTGTATAGATTACAGATAT 1921 AATTTATTGTGATAACAAATGGCTTCCTGTTTGACCTCATTTCCAGGTGTCGCATCCGTGGCTGATTTATTTCACAGATG 2001 TACATTTGCATGTACTTGTTGAACTTTGCTAGGAAGGACTCAATTTTTGAAAAATCTGTTATTTTCACTGTGGGCCTTAT 2081 GAGGCAATCTACTGCAATGGAAAAAGGGTTCCTTGGTCATTTCAAGTTTTATTTTCTATTAGAGTAATATCTAACTTCAA 2161 TTATTTTGCCAGGTTTAAACCTTCTCTCTGTGTCTGTGGTTAGAATTTGAAAATAACAATGCTCTGCTTAAAGTAAGAGT 2241 CACAGTCAGCAAAAAAAGCCAATGGATTTTAAAAAGACATCTTAGTTAAAGCTAGAGGAAGAAAACTTCAAATAAGCAAA 2321 GAAGTATTGAAGGATGCCCACGAATTCCTTTGCATTAAAATCAAGATGAGGTAAGAGGTAGAATATAAGAGAAAGGGATT 2401 ATTTTTACCATGAATTGTATCTGGGGACAGTTAGTCTTAGAAGGAGTAATTTTTTCAGCGTTTTTCCTCTGTATCTAAAC 2481 ACCAATAATATACTTAATTTTTGAATATAAAAGAAGTAGCAATTGACTAAGAATAAATATGTTATAAAAACTAGGGGATT 2561 ATCTTGATTTACATTTCCTAGAGTATTAAAAGAGATTAATTACAGACTTTCACTTGATAATATTGAGGAGTCTGGAGGGT 2641 CATAGCAAAATTTTCTTTAGTTCATCTTAAAATTTAGGGAGGTAAAAAAAGATTTTATTCACATAAAAGATTTCTTGGCA 2721 TAGGGAAGGCGTAATGTTAAGGGCTTCTTCCTTACCCAAGTGGGAGCTGAACCAGTAATTGTGGGGAAAACTGAATTTAT 2801 AGCAACAAAGGATAGTAGTTTCTCAACTGGGAGCATACGAGCAATTTCTCAGTTCAGAGATATTTATAGCATCTTGGTGT 2881 TATGCAATAAACAATGACAACAACAAGCATTGAGCTTTCACTTTGGAGTTACTCAGATCTGAGTTTAAATTCTAAAATTA 2961 TTCTAGTAGTATTTTCCTGCGGTGAATCTGTTAAGGATGTAAGCTATAGTGTAGCTTGGGGAATCATCTTGAACAGTTAT 3041 GAAACTCATTAAAGCTTCTTTTCCCTTGTCTGTAAAATGGGAAAAATAAATACCTCTATAGCTCTTAAGAGGCTTAAGAG 3121 TTCTATGGCTTACACCCACATACAGTCCTTGGCTCAGTGCTAGGCATGTAGCAGGTGCTGACTGCCTCTCTCCCTTCCCT 3201 TCTTTACTCTCAGTTGTCTTATTTCTTCTTATGCAGAAGAGATTACCTTAAAGCTGACTAGAAAACTCAGACATAAATTG 3281 ACATTTCCTTATCATTGCCTGAAACCCACTGAATAAGTCCCCTTTGATTTCTCTCAGGAAGGATAAAAAAGGCTACAGTA 3361 CCTGCTCATAGGAGTTCAGTAAATGTTTATTGATTGAATGAAAAGAATTTGATTTAAGGAAACAATAACACTCCATCCTG 3441 GGCAACAGAGCAAGATCCCGTCTCAAAACAAAACAAAACAAAACAAAACAGCAAATTCATAAAGGCCAGCAGTTTTCAAG 3521 TCTGGGGAAATAGGCACATGGACAGATTATATGAAGGTATTTCATTAGCTTTCTTCTCTTTATGGCAGCTTCAGATTGAT 3601 GAATTTGAGGTACAAATGAGTGAGTGACATATGTATATTTTCCTCTGATTTTATGACTGATTTACAAATTAGGAGTGCAA 3681 ATGGGCTGTTCCCCGATAGCATCTTCTGGGAAGAATCCAACCAAGATACAAAGCAGATGATGGTGGATCGGCAAACTCTT 3761 TTCTATGAAAAGAAAAACCAGATATACCAGGGACTGGAAAGCACCTGCTTGAAAATTGATATGAGCATGTCTGAATTTTT 3841 CCCTTATAAGAGCCTGAGTATTGTAACAGGTCTCTTGCACAGGGGGTTGAAAAATAAAAAAAGAAGTTAACATAATTAAA 3921 ATGCTTGGACAAAACATTTGCTTTATATAGATTCTTACAAGTAATATTTGATTAGGTATCAAAATAGGTTTAGGCAGGTG 4001 GAAGTTCTGAATTTCAAGGCAAATAAGGCATGAAGGGTGGAACATTGCATCTAGGGAAAATAAGAGAAATAAGTGAAAGT 4081 CTGACCCTACATTGCCAATTCTCAGACCAAGTACAAAGTATTAGGAATTTTTTATATCAGCTGACATCTTGTGCTTACAG 4161 TAAAGCCATATAGATGCACACATAGTGACTTTATTAAATCAAATGAGTTGTGCAGAGCAGAGCAAATCTATTAGGCTTTC 4241 TCTTTTAGAGTTTTCTAATTTTACTCTTATTAGCTCCCTCAGTTGTCATCAATTACATATTCCTACATCAGATATTTTAC 4321 ACTATCAGATTCTTTGATTAAAAAATCATCTTCAGCTTTACATTATTAATCTCTGAGGACATAAAATCAAATAACTTTCT 4401 AGTCCATGATCATTAATCCCTACTATTTTAGATATTTCCATAAAAGGCTTAAAGGGAAAAAAAAATGGTAGGTAGTTCAG 4481 AAAAAAATGGCTGGGCACGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCGGGGTGGGCAGATCATTTGAGGTC 4561 AGGAGTTTGAGACCAGCCTGGCCAACATGGTGAAACCCTGTGTCTACTAAAAATACAAAAAAAATTAGCTGAGTGTGGTG 4641 GTGTGCGCCTGTAATCCCAGCTACTAAGGCAGGAGAATGGCTTGAACCCAGGAGGTGGAGGTCGCAGTGAGCTGAGATCG 4721 CGCCAGTGCGCTCCAGCCTGGGCAACAGAGTGAGACTCTGTCTAAAAAAAAAAAAAAAAGAAAAGAAAAAAGAAAAATTG 4801 AAGAACATAACTTTTCTACTTATGAAATAGATAATTTTTTAAAATTGTTTAAACTCCTGGAAATTAAGTGTTATTTTTTA 4881 TTACTGCAGTTGAGAGATACCTTTTCAGAGGAAAACAAGAGGCTAAATTCCATGTTAAGAGCTAAGTAGTATTTTTTTCT 4961 TAACAATTTTGCCAAAATTTCTTCTACTGGACCAAAAGGAAATAAATCTACAATAAATCTACTTTCTAAATATTATTTAA 5041 GATGGGAAATGTCTTTTATAGGTATATTCTGTATAATACCCTTAATTAGATGAATTATCCCTTATCATTCCAAAAATGAA 5121 ATGCTGTGTTAAATATCTCCAGGGCAAAGTGGTATGTTGACTGGGACAAACGTTAGAAATTGTATTGTTCATTGCACTTG 5201 TTGCCCTGTTCCCCAAGCTTGTCAATGTTTAGAGATACTATTCGGGTTGCTAAAGCCATTATTCATAGAAAATTTCTGCC 5281 CCTACAGAAGTGTGTGCATGGGCCTTGGAAAATCTACATGTGTATATCTGAGTAGCGAAGCACAGATTCACTCTAATTGA 5361 AAGCAGCAGTTTGGTTTTGTAAATGTAATTGCAATTGACACTTTCTTTTCCCTTTCAGTTATTATTTTTTTTAAAGGACG 5441 TTATGAGAAGGCACTATGAAAAGCCTAATTGGAATAGCATTATGAACCATGTAATGCATGCCCATGCACACTGTGATTTG 5521 CAAACATATGTCCGCTCTTCAATAAATGTTACGGCTTTCACAGCG Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 389432.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714646. RNA binding protein: AGO2. Condition:mildMNase
"PAR-CLIP data was present in GSM714647. RNA binding protein: AGO2. Condition:mildMNase
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
CLIP-seq Support 1 for dataset GSM714646 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / mildMNase, repA |
Location of target site | ENST00000367474.1 | 3UTR | GAACCCAGGAGGUGGAGGUCGCAGUGAGCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM714647 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / mildMNase, repB |
Location of target site | ENST00000367474.1 | 3UTR | AACCCAGGAGGUGGAGGUCGCAGUGAGCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
131 hsa-miR-23a-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT038958 | ATF1 | activating transcription factor 1 | 1 | 1 | ||||||||
MIRT057661 | LCOR | ligand dependent nuclear receptor corepressor | 2 | 2 | ||||||||
MIRT395438 | NFKBID | NFKB inhibitor delta | 2 | 2 | ||||||||
MIRT463884 | WNT7B | Wnt family member 7B | 2 | 4 | ||||||||
MIRT475804 | HDGF | heparin binding growth factor | 2 | 2 | ||||||||
MIRT478528 | CTNS | cystinosin, lysosomal cystine transporter | 2 | 2 | ||||||||
MIRT479278 | CHD4 | chromodomain helicase DNA binding protein 4 | 2 | 6 | ||||||||
MIRT492564 | PPM1L | protein phosphatase, Mg2+/Mn2+ dependent 1L | 2 | 2 | ||||||||
MIRT500353 | ZNF385A | zinc finger protein 385A | 2 | 2 | ||||||||
MIRT509788 | CHAF1B | chromatin assembly factor 1 subunit B | 2 | 4 | ||||||||
MIRT511566 | HIST3H2BB | histone cluster 3 H2B family member b | 2 | 4 | ||||||||
MIRT525450 | GPATCH2L | G-patch domain containing 2 like | 2 | 2 | ||||||||
MIRT539558 | CNKSR3 | CNKSR family member 3 | 2 | 4 | ||||||||
MIRT540034 | DNAJC28 | DnaJ heat shock protein family (Hsp40) member C28 | 2 | 4 | ||||||||
MIRT540225 | SAMD5 | sterile alpha motif domain containing 5 | 2 | 2 | ||||||||
MIRT540242 | RGS17 | regulator of G protein signaling 17 | 2 | 2 | ||||||||
MIRT540871 | ZBTB24 | zinc finger and BTB domain containing 24 | 2 | 2 | ||||||||
MIRT559065 | C19orf47 | chromosome 19 open reading frame 47 | 2 | 4 | ||||||||
MIRT560685 | HIST1H1T | histone cluster 1 H1 family member t | 2 | 2 | ||||||||
MIRT565593 | SLC35G1 | solute carrier family 35 member G1 | 2 | 2 | ||||||||
MIRT565642 | SKI | SKI proto-oncogene | 2 | 2 | ||||||||
MIRT576747 | Tmem127 | transmembrane protein 127 | 2 | 2 | ||||||||
MIRT607712 | LIMS1 | LIM zinc finger domain containing 1 | 2 | 2 | ||||||||
MIRT615682 | NAV2 | neuron navigator 2 | 2 | 2 | ||||||||
MIRT617337 | ZSCAN2 | zinc finger and SCAN domain containing 2 | 2 | 2 | ||||||||
MIRT617378 | FAM227A | family with sequence similarity 227 member A | 2 | 2 | ||||||||
MIRT620855 | SERPING1 | serpin family G member 1 | 2 | 2 | ||||||||
MIRT625112 | SLC1A5 | solute carrier family 1 member 5 | 2 | 2 | ||||||||
MIRT625124 | NUP93 | nucleoporin 93 | 2 | 2 | ||||||||
MIRT625898 | LINC00632 | long intergenic non-protein coding RNA 632 | 2 | 2 | ||||||||
MIRT626016 | XRCC2 | X-ray repair cross complementing 2 | 2 | 2 | ||||||||
MIRT626481 | ADAT1 | adenosine deaminase, tRNA specific 1 | 2 | 2 | ||||||||
MIRT626573 | MED7 | mediator complex subunit 7 | 2 | 2 | ||||||||
MIRT626814 | PRR11 | proline rich 11 | 2 | 2 | ||||||||
MIRT628136 | HM13 | histocompatibility minor 13 | 2 | 2 | ||||||||
MIRT630771 | MSANTD3 | Myb/SANT DNA binding domain containing 3 | 2 | 2 | ||||||||
MIRT633133 | C6orf132 | chromosome 6 open reading frame 132 | 2 | 2 | ||||||||
MIRT636950 | APTX | aprataxin | 2 | 2 | ||||||||
MIRT637802 | GGPS1 | geranylgeranyl diphosphate synthase 1 | 2 | 2 | ||||||||
MIRT638622 | GSR | glutathione-disulfide reductase | 2 | 4 | ||||||||
MIRT642196 | SMAGP | small cell adhesion glycoprotein | 2 | 2 | ||||||||
MIRT645121 | HES2 | hes family bHLH transcription factor 2 | 2 | 2 | ||||||||
MIRT645344 | AGTPBP1 | ATP/GTP binding protein 1 | 2 | 2 | ||||||||
MIRT646564 | ALDH5A1 | aldehyde dehydrogenase 5 family member A1 | 2 | 2 | ||||||||
MIRT649243 | TRIM65 | tripartite motif containing 65 | 2 | 2 | ||||||||
MIRT651810 | USP49 | ubiquitin specific peptidase 49 | 2 | 2 | ||||||||
MIRT652137 | TRPM7 | transient receptor potential cation channel subfamily M member 7 | 2 | 2 | ||||||||
MIRT652668 | TIMELESS | timeless circadian clock | 2 | 2 | ||||||||
MIRT655894 | NEK9 | NIMA related kinase 9 | 2 | 2 | ||||||||
MIRT656564 | LYRM7 | LYR motif containing 7 | 2 | 2 | ||||||||
MIRT657194 | IKZF3 | IKAROS family zinc finger 3 | 2 | 2 | ||||||||
MIRT657907 | GDE1 | glycerophosphodiester phosphodiesterase 1 | 2 | 2 | ||||||||
MIRT660207 | BMPR1A | bone morphogenetic protein receptor type 1A | 2 | 2 | ||||||||
MIRT660619 | ANKS4B | ankyrin repeat and sterile alpha motif domain containing 4B | 2 | 2 | ||||||||
MIRT660826 | AGO3 | argonaute 3, RISC catalytic component | 2 | 2 | ||||||||
MIRT660986 | ABHD2 | abhydrolase domain containing 2 | 2 | 2 | ||||||||
MIRT662232 | PGBD4 | piggyBac transposable element derived 4 | 2 | 2 | ||||||||
MIRT663691 | ZNF347 | zinc finger protein 347 | 2 | 2 | ||||||||
MIRT665577 | TUBD1 | tubulin delta 1 | 2 | 2 | ||||||||
MIRT666149 | SP2 | Sp2 transcription factor | 2 | 2 | ||||||||
MIRT666310 | SLC22A3 | solute carrier family 22 member 3 | 2 | 2 | ||||||||
MIRT666457 | SCRG1 | stimulator of chondrogenesis 1 | 2 | 2 | ||||||||
MIRT667716 | KIAA1468 | KIAA1468 | 2 | 2 | ||||||||
MIRT668329 | FKBP5 | FK506 binding protein 5 | 2 | 2 | ||||||||
MIRT668370 | FBXO47 | F-box protein 47 | 2 | 2 | ||||||||
MIRT669304 | C17orf75 | chromosome 17 open reading frame 75 | 2 | 2 | ||||||||
MIRT669538 | ALG9 | ALG9, alpha-1,2-mannosyltransferase | 2 | 2 | ||||||||
MIRT671681 | ADK | adenosine kinase | 2 | 2 | ||||||||
MIRT672177 | MRE11A | MRE11 homolog, double strand break repair nuclease | 2 | 2 | ||||||||
MIRT673604 | HPSE | heparanase | 2 | 2 | ||||||||
MIRT673749 | ZNF333 | zinc finger protein 333 | 2 | 2 | ||||||||
MIRT674807 | FAM229B | family with sequence similarity 229 member B | 2 | 2 | ||||||||
MIRT675286 | ARL10 | ADP ribosylation factor like GTPase 10 | 2 | 2 | ||||||||
MIRT675391 | SVOP | SV2 related protein | 2 | 2 | ||||||||
MIRT675788 | MED28 | mediator complex subunit 28 | 2 | 2 | ||||||||
MIRT676151 | OGFOD1 | 2-oxoglutarate and iron dependent oxygenase domain containing 1 | 2 | 2 | ||||||||
MIRT676499 | GJD3 | gap junction protein delta 3 | 2 | 2 | ||||||||
MIRT676621 | CSNK1E | casein kinase 1 epsilon | 2 | 2 | ||||||||
MIRT676644 | GTDC1 | glycosyltransferase like domain containing 1 | 2 | 2 | ||||||||
MIRT676711 | METTL14 | methyltransferase like 14 | 2 | 2 | ||||||||
MIRT676809 | SHROOM4 | shroom family member 4 | 2 | 2 | ||||||||
MIRT677036 | FOXO3 | forkhead box O3 | 2 | 2 | ||||||||
MIRT677062 | NT5C2 | 5'-nucleotidase, cytosolic II | 2 | 2 | ||||||||
MIRT677086 | SMIM15 | small integral membrane protein 15 | 2 | 2 | ||||||||
MIRT677193 | MURC | caveolae associated protein 4 | 2 | 2 | ||||||||
MIRT677273 | SNRPD1 | small nuclear ribonucleoprotein D1 polypeptide | 2 | 2 | ||||||||
MIRT677345 | POC1A | POC1 centriolar protein A | 2 | 2 | ||||||||
MIRT677504 | SLC10A6 | solute carrier family 10 member 6 | 2 | 2 | ||||||||
MIRT677526 | OCIAD2 | OCIA domain containing 2 | 2 | 2 | ||||||||
MIRT677661 | UGGT1 | UDP-glucose glycoprotein glucosyltransferase 1 | 2 | 2 | ||||||||
MIRT677727 | SSR1 | signal sequence receptor subunit 1 | 2 | 2 | ||||||||
MIRT677803 | PNPLA3 | patatin like phospholipase domain containing 3 | 2 | 2 | ||||||||
MIRT678144 | SLC4A4 | solute carrier family 4 member 4 | 2 | 2 | ||||||||
MIRT678376 | VTA1 | vesicle trafficking 1 | 2 | 2 | ||||||||
MIRT678708 | DHTKD1 | dehydrogenase E1 and transketolase domain containing 1 | 2 | 2 | ||||||||
MIRT678868 | FAM118A | family with sequence similarity 118 member A | 2 | 2 | ||||||||
MIRT679039 | LACTB | lactamase beta | 2 | 2 | ||||||||
MIRT679081 | PURB | purine rich element binding protein B | 2 | 2 | ||||||||
MIRT679137 | SYK | spleen associated tyrosine kinase | 2 | 2 | ||||||||
MIRT679299 | SSBP2 | single stranded DNA binding protein 2 | 2 | 2 | ||||||||
MIRT679741 | CABP4 | calcium binding protein 4 | 2 | 2 | ||||||||
MIRT679946 | AS3MT | arsenite methyltransferase | 2 | 2 | ||||||||
MIRT679976 | E2F2 | E2F transcription factor 2 | 2 | 2 | ||||||||
MIRT683628 | MTO1 | mitochondrial tRNA translation optimization 1 | 2 | 2 | ||||||||
MIRT683901 | PSMB9 | proteasome subunit beta 9 | 2 | 2 | ||||||||
MIRT684172 | MOG | myelin oligodendrocyte glycoprotein | 2 | 2 | ||||||||
MIRT684231 | C20orf144 | chromosome 20 open reading frame 144 | 2 | 2 | ||||||||
MIRT685403 | C1orf158 | chromosome 1 open reading frame 158 | 2 | 2 | ||||||||
MIRT686253 | ZBTB8B | zinc finger and BTB domain containing 8B | 2 | 2 | ||||||||
MIRT687513 | NCKAP1 | NCK associated protein 1 | 2 | 2 | ||||||||
MIRT688243 | FITM2 | fat storage inducing transmembrane protein 2 | 2 | 2 | ||||||||
MIRT688315 | FAM151B | family with sequence similarity 151 member B | 2 | 2 | ||||||||
MIRT688733 | CNDP1 | carnosine dipeptidase 1 | 2 | 2 | ||||||||
MIRT689031 | ANGPTL3 | angiopoietin like 3 | 2 | 2 | ||||||||
MIRT698207 | TMEM248 | transmembrane protein 248 | 2 | 2 | ||||||||
MIRT699859 | SAR1A | secretion associated Ras related GTPase 1A | 2 | 2 | ||||||||
MIRT709954 | TRUB2 | TruB pseudouridine synthase family member 2 | 2 | 2 | ||||||||
MIRT711541 | MSH3 | mutS homolog 3 | 2 | 2 | ||||||||
MIRT712077 | WDR37 | WD repeat domain 37 | 2 | 2 | ||||||||
MIRT715312 | POLR2E | RNA polymerase II subunit E | 2 | 2 | ||||||||
MIRT715725 | PIAS2 | protein inhibitor of activated STAT 2 | 2 | 2 | ||||||||
MIRT715748 | HSD11B1L | hydroxysteroid 11-beta dehydrogenase 1 like | 2 | 2 | ||||||||
MIRT717604 | DSTYK | dual serine/threonine and tyrosine protein kinase | 2 | 2 | ||||||||
MIRT717875 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | 2 | 2 | ||||||||
MIRT718042 | NIPAL2 | NIPA like domain containing 2 | 2 | 2 | ||||||||
MIRT718829 | CDT1 | chromatin licensing and DNA replication factor 1 | 2 | 2 | ||||||||
MIRT724037 | CAMK2N2 | calcium/calmodulin dependent protein kinase II inhibitor 2 | 2 | 2 | ||||||||
MIRT733305 | TNF | tumor necrosis factor | 1 | 0 | ||||||||
MIRT734941 | HSPA1B | heat shock protein family A (Hsp70) member 1B | 3 | 0 | ||||||||
MIRT737343 | IGF2 | insulin like growth factor 2 | 3 | 0 | ||||||||
MIRT737546 | PTEN | phosphatase and tensin homolog | 2 | 0 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|